Jonathan Wilcox speaks on how a recent Institute for Clinical and Economic Review report and other value frameworks are affecting patient care.
Journal of Clinical Pathways spoke with Dr Christopher Lathan about the relationship between financial distress and cancer outcomes.
Journal of Clinical Pathways spoke with Mark Boguski, MD, PhD, the co-founder and chief medical officer of Precision Medicine Network and a leading expert in precision medicine.
Journal of Clinical Pathways spoke with Leonard Saltz, MD, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center, and Peter B Bach, MD, director at the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, two health care professionals leading the conversation about unsustainable cost growth associated with cancer treatment.
Vikas Saini, MD discusses some of the issues facing the American health care system as well as what Right Care Alliance is trying to do to fix them.
Daniel Wolfson, MHSA, spoke with the Journal of Clinical Pathways about the pervasive issue of duplicative or unnecessary treatment in health care.
Journal of Clinical Pathways spoke with two leaders at the Dana-Farber Cancer Institute about their experiences implementing clinical pathways.
Howard L Kaufman, MD, discussed what the future holds for immunotherapies and the role they will likely play within pathways.
Robin T Zon, MD, spoke on the ASCO policy statement on clinical pathways and the areas in which pathways most need to improve.
Journal of Clinical Pathways spoke with Geoffrey P. Dunn, MD, about the growth of formal palliative care programs.